Literature DB >> 28319497

Vertebral Hemangioma Mimicking Bone Metastasis in 68Ga-PSMA Ligand PET/CT.

Carlos Artigas1, François-Xavier Otte, Marc Lemort, Roland van Velthoven, Patrick Flamen.   

Abstract

Ga-PSMA PET/CT was performed in a 68-year-old man to evaluate recurrent prostate cancer due to elevated serum prostate-specific antigen level. Images showed a focal uptake in the prostatic gland, suggesting local relapse, and an intense uptake in the 12th thoracic vertebra, with no morphological abnormalities in CT slices. In order to confirm extraprostatic disease and before radiotherapy planning, a full-spine MRI was performed, resulting with the morphological pattern of a vertebral hemangioma. Hystological analysis confirmed the local relapse in the prostate. No radiotherapy treatment was given to the vertebra, and after 1 year of follow-up without systemic treatment, prostate-specific antigen is still undetectable.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28319497     DOI: 10.1097/RLU.0000000000001631

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  [68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients.

Authors:  Jan-Carlo Janssen; Nadine Woythal; Sebastian Meißner; Vikas Prasad; Winfried Brenner; Gerd Diederichs; Bernd Hamm; Marcus R Makowski
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

2.  [68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.

Authors:  Frédéric Bois; Camille Noirot; Sébastien Dietemann; Ismini C Mainta; Thomas Zilli; Valentina Garibotto; Martin A Walter
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

Review 3.  PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies.

Authors:  Ahmed Ebada Salem; Gabriel C Fine; Matthew F Covington; Bhasker R Koppula; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 4.  The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence.

Authors:  Jie Jiang; Xiaoxia Tang; Yongzhu Pu; Yong Yang; Conghui Yang; Fake Yang; Yadong Tian; Jindan Li; Hua Sun; Sheng Zhao; Long Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-27       Impact factor: 6.055

Review 5.  Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.

Authors:  Philipp Backhaus; Benjamin Noto; Nemanja Avramovic; Lena Sophie Grubert; Sebastian Huss; Martin Bögemann; Lars Stegger; Matthias Weckesser; Michael Schäfers; Kambiz Rahbar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-01-15       Impact factor: 9.236

Review 6.  Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Authors:  Sara Sheikhbahaei; Ali Afshar-Oromieh; Matthias Eiber; Lilja B Solnes; Mehrbod S Javadi; Ashley E Ross; Kenneth J Pienta; Mohamad E Allaf; Uwe Haberkorn; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-01       Impact factor: 9.236

7.  Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain.

Authors:  Felipe Couñago; Claudio Martínez-Ballesteros; Carlos Artigas; Ana Aurora Díaz-Gavela; Luis Leonardo Guerrero Gómez; María Eugenia Lillo-García; José Reinaldo Chicharo; Manuel Recio; Antonio Maldonado; Israel J Thuissard; Cristina Andreu-Vázquez; David Sanz-Rosa; Antonio José Conde-Moreno; Francisco José Marcos; Sofía Sánchez García; Juan Ignacio Martínez-Salamanca; Joaquin Carballido-Rodríguez; Javier Hornedo; Elia Del Cerro
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-12

8.  18F DCFPyL PSMA avid biopsy proven subcutaneous capillary haemangioma as a malignancy mimic in the setting of biochemical recurrent prostate carcinoma.

Authors:  Manvinder Dhillon; Dalveer Singh
Journal:  Radiol Case Rep       Date:  2022-04-19

Review 9.  Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings.

Authors:  Felipe de Galiza Barbosa; Marcelo Araujo Queiroz; Rafael Fernandes Nunes; Larissa Bastos Costa; Elaine Caroline Zaniboni; José Flavio Gomes Marin; Giovanni Guido Cerri; Carlos Alberto Buchpiguel
Journal:  Cancer Imaging       Date:  2020-03-14       Impact factor: 3.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.